EilandMSHuntMO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010;12:379-389.
2.
LiptonRBManackARicciJACheeETurkelCCWinnerP. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study(C-dAS). Headache. 2011;51:693-706.
3.
JelinskiSEBeckerWJChristieSN. Demographics and clinical features of patients referred to headache clinics. Can J Neurol Sci. 2006;33:228-234.
4.
WinnerPPearlmanEMLinderSLJordanDMFisherACHulihanJ; Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45:1304-1312.
5.
LewisDAshwalSHersheyAHirtzDYonkerMSilbersteinS. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215-2224.
6.
LiptonRBBigalMEDiamondMFreitagFReedMLStewardWF; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349.
7.
AhonenKHämäläinenMLEerolaMHoppuK. A randomized trial of rizatriptan in migraine attacks in children. Neurology. 2006;67:1135-1140.
8.
LinderSLMathewNTCadyRKFinlaysonGIshkanianGLewisDW. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache. 2008;48:1326-1336.
9.
Oelkers-AxRLeinsAParzerP. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain. 2008;12:301-313.
10.
MaskiKPJesteSSDarrasBT. Child neurology: past, present, and future: part 2: present training structure. Neurology. 2010;74:e17-e19.